Research News and Research

RSS

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Patients under immunosuppressive therapy, who do not respond to primary COVID-19 vaccination, have an increased risk for severe COVID-19 disease courses. Until now, it was not clear whether those patients at risk can benefit from an additional booster vaccination.

26 Jan 2022

Microbiome 'profiling' may help identify people at risk of long COVID

The make-up of the gut microbiome may be linked to a person's risk of developing 'long COVID' many months after initial infection with SARS-CoV-2, the virus responsible for COVID-19 infection, suggests research published online in the journal Gut.

26 Jan 2022

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

A new study assesses SARS-CoV-2 antigen-specific cytokine responses in a cohort of SARS-CoV-2 infected individuals with varying levels of disease.

26 Jan 2022

Study finds link between lifetime workplace exposure to pesticides and elevated COPD risk

Lifetime workplace exposure to pesticides is linked to a heightened risk of COPD, the umbrella term for a group of respiratory diseases that cause airflow blockage and breathing problems, finds a large population based study, published online in the journal Thorax.

26 Jan 2022

Research reveals the burden of aortic valve stenosis in the UK

An estimated 300,000 people in the UK have aortic valve stenosis, a progressive and potentially fatal condition, suggests research published in the open access journal Open Heart.

26 Jan 2022

New research on SARS-CoV-2 Omicron and care home residents

Researchers find a reduced risk of hospitalizations and deaths in long term care facility residents infected with SARS-CoV-2 Omicron variant.

26 Jan 2022

Hospitalization for COVID-19 may increase the risk of later readmission or death

People who had been hospitalized for COVID-19 in 2020 - and survived for at least one week after discharge - were more than twice as likely to die or be readmitted to the hospital in the next several months compared to the general population, according to new research in PLOS Medicine.

26 Jan 2022

Study explores how cannabis use affects driving performance

The steady rise in the use of cannabis - 18 states have legalized recreational use, 13 have decriminalized its use and 36 have medical cannabis laws - has provoked myriad questions and concerns about public health implications, including how cannabis may affect the abilities, real and perceived, of drivers under the influence.

26 Jan 2022

Language used to describe 'long COVID' can impact patient outcomes

Researchers utilize an online experimental platform to explore the effect of different messages about long COVID on expectations of illness outcomes.

26 Jan 2022

Macromolecular gel with therapeutic payload could halt or slow post-traumatic osteoarthritis

Osteoarthritis affects over 32 million Americans, levying a huge cost on society. Unfortunately, other than analgesics, no pharmaceutical therapy exists that can slow or halt disease progression of a major subset of OA: post-traumatic osteoarthritis (PTOA).

26 Jan 2022

Gastrointestinal hormone shows promise for the treatment of heart and kidney failure

The gastrointestinal hormone secretin- often associated with its role in the pancreas- increases and improves both heart and kidney function, according to a new study.

26 Jan 2022

Study provides a new treatment option for patients with relapsed B-cell lymphoma

A new therapy showed improvement over the standard treatment for relapsed B-cell lymphoma, according to a study published in the New England Journal of Medicine.

26 Jan 2022

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the U.S. Food and Drug Administration, an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results reported in The New England Journal of Medicine.

26 Jan 2022

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

The Centers for Disease Control and Prevention reached out to pharmacists Wednesday to reinforce the message that people with moderate to severe immune suppression are eligible for fourth covid shots.

26 Jan 2022

More than 5,000 people enrolled in PANORAMIC study for COVID-19 antivirals

Over 5,000 vulnerable people have now enrolled into a world-class study for the chance to receive life-saving antivirals, the government has announced today (Wednesday 26 January 2022).

26 Jan 2022

Breast cancer drug shows promise in treating young infants with PIK3CA-related overgrowth spectrum

PIK3CA-related overgrowth spectrum (PROS) is a group of rare, incurable disorders caused by mutations in the PIK3CA gene that result in the malformation and overgrowth of various parts of the body.

26 Jan 2022

What the federal ‘No Surprises Act’ means in California

Betty Chow, a Los Angeles resident, had a cervical disc replaced in August 2020 at a surgery center that was part of her Anthem Blue Cross PPO network.

26 Jan 2022

After miscarriages, workers have few guarantees for time off or job-based help

For three years, Rachel Makkar said, she thrived in her job as a broker and asset manager at J&B Building Co. in Colorado. She excelled at her work — she said her performance reviews noted that — and she thought it was "the best place I've ever worked."

26 Jan 2022

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

An interdisciplinary team of researchers from Europe analyzed the alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients.

26 Jan 2022

Endosomal sorting of neuropilin-1 in SARS-CoV-2 infectivity

A study recently identified Neurolipin-1 or NRP1, a host factor for SARS-CoV-2 infection, as a cargo retrograde-transported by the ESCPE-1.

26 Jan 2022

Research News and Research

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Microbiome 'profiling' may help identify people at risk of long COVID

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

Study finds link between lifetime workplace exposure to pesticides and elevated COPD risk

Research reveals the burden of aortic valve stenosis in the UK

New research on SARS-CoV-2 Omicron and care home residents

Hospitalization for COVID-19 may increase the risk of later readmission or death

Study explores how cannabis use affects driving performance

Language used to describe 'long COVID' can impact patient outcomes

Macromolecular gel with therapeutic payload could halt or slow post-traumatic osteoarthritis

Gastrointestinal hormone shows promise for the treatment of heart and kidney failure

Study provides a new treatment option for patients with relapsed B-cell lymphoma

Homologous and heterologous COVID-19 booster vaccines found to be safe and immunogenic

CDC tells pharmacies to give 4th covid shots to immunocompromised patients

More than 5,000 people enrolled in PANORAMIC study for COVID-19 antivirals

Breast cancer drug shows promise in treating young infants with PIK3CA-related overgrowth spectrum

What the federal ‘No Surprises Act’ means in California

After miscarriages, workers have few guarantees for time off or job-based help

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Endosomal sorting of neuropilin-1 in SARS-CoV-2 infectivity

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence